Health Care & Life Sciences » Pharmaceuticals | Samsung Pharmaceutical Co. Ltd.

Samsung Pharmaceutical Co. Ltd.

Samsung Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW53.51
Market Cap
KRW147.3 B
Shares Outstanding
58.61 M
Public Float
50.32 M

Profile

Address
35 Jeyakgongdan 2-gil
Hwaseong-si GY 18622
Korea, Republic Of
Employees -
Website http://www.sspharm.co.kr
Updated 07/08/2019
Samsung Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. It operates through the following business divisions: Pharmaceutical, Cosmetics, and Healthy Food. The Pharmaceutical divsion provides medicines for digestion, antibiotics, intestine, alleviation of fever, and cerebral apoplexy.

Financials

View All
Created with Highcharts 5.0.14Samsung Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.18 48918 48923 74823 74899499417 21817 2187 2747 2742 0762 07620132014201520162017201805k10k15k20k25k
Created with Highcharts 5.0.14Samsung Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.46 92146 92130 28830 28842 16542 16547 19447 19441 91941 91946 48446 484201320142015201620172018010k20k30k40k50k

Ki-Ho Kim
Co-Chief Executive Officer & Director
Sang-Jae Kim
Co-Chief Executive Officer & Director